Holen Sie sich die Stockscreener-App
6.57
2.66%
0.17
Handel nachbörslich:
6.58
0.010
+0.15%
Schlusskurs vom Vortag:
$6.40
Offen:
$6.49
24-Stunden-Volumen:
894.49K
Relative Volume:
0.66
Marktkapitalisierung:
$665.95M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-167.48M
KGV:
-3.3692
EPS:
-1.95
Netto-Cashflow:
$-197.47M
1W Leistung:
+0.00%
1M Leistung:
+3.96%
6M Leistung:
-46.93%
1J Leistung:
-55.82%
1-Tages-Spanne:
$6.42
$6.64
1-Wochen-Bereich:
$6.32
$6.73
52-Wochen-Spanne:
$6.08
$16.76
Day One Biopharmaceuticals Inc Stock (DAWN) Company Profile
Firmenname
Day One Biopharmaceuticals Inc
Sektor
Branche
Telefon
650 484-0899
Adresse
2000 SIERRA POINT PARKWAY, SUITE 501, BRISBANE
Vergleichen Sie DAWN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DAWN
Day One Biopharmaceuticals Inc
|
6.57 | 665.95M | 0 | -167.48M | -197.47M | -1.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Day One Biopharmaceuticals Inc Stock (DAWN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-09 | Bestätigt | Needham | Buy |
| 2024-08-01 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-04-24 | Bestätigt | Needham | Buy |
| 2023-04-25 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-08 | Eingeleitet | CapitalOne | Overweight |
| 2023-02-03 | Eingeleitet | Oppenheimer | Perform |
| 2022-12-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-12-14 | Eingeleitet | Needham | Buy |
| 2022-12-05 | Eingeleitet | Goldman | Buy |
| 2022-12-01 | Eingeleitet | BofA Securities | Buy |
Alle ansehen
Day One Biopharmaceuticals Inc Aktie (DAWN) Neueste Nachrichten
What analysts say about Day One Biopharmaceuticals Inc. stockConsistently high yield - Autocar Professional
What makes Day One Biopharmaceuticals Inc. stock price move sharplyConsistent High Return Strategy - Newser
Day One Biopharmaceuticals Inc. Stock Analysis and ForecastRapid capital growth - jammulinksnews.com
Is Day One Biopharmaceuticals Inc. a good long term investmentSkyrocketing profit margins - jammulinksnews.com
What drives Day One Biopharmaceuticals Inc. stock priceFree Daily Trading Room Entry - jammulinksnews.com
Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025 - GlobeNewswire
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Sold by Teacher Retirement System of Texas - Defense World
How Day One Biopharmaceuticals Inc. stock performs during market volatilityFree Access to Community - Newser
Why Day One Biopharmaceuticals Inc. stock attracts strong analyst attentionTop Performing Low Risk Stocks - Newser
When the Price of (DAWN) Talks, People Listen - news.stocktradersdaily.com
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Recommendation of “Buy” by Brokerages - Defense World
Wealth Enhancement Advisory Services LLC Makes New $88,000 Investment in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Day One Announces Pricing of Upsized Initial Public Offering - IT Business Net
Day One Biopharmaceuticals, Inc. shares rise 4.16% intraday after positive mid-term outlook from Lonza Group. - AInvest
DAY ONE BIOPHARMACEUTICALS Earnings Preview: Recent $DAWN Insider Trading, Hedge Fund Activity, and More - Nasdaq
AMPY Stock: A Voyage Through Amplify Energy Corp’s Finances - investchronicle.com
(DAWN) On The My Stocks Page - news.stocktradersdaily.com
When Will Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Breakeven? - Yahoo Finance
TimesSquare Capital U.S. Small Cap Growth Strategy Exited its Position in Day One Biopharmaceuticals Inc. (DAWN) - MSN
Is Day One Biopharmaceuticals, Inc. overvalued or undervalued? - MarketsMojo
Day 9 of Loss Streak for Day One Biopharmaceuticals Stock with -12% Return (vs. -50% YTD) [6/20/2025] - Trefis
Day 8 of Loss Streak for Day One Biopharmaceuticals Stock with -11% Return (vs. -49% YTD) [6/18/2025] - Trefis
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Rating of “Buy” by Brokerages - Defense World
Pallas Capital Advisors LLC Takes Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Bank of America Corp DE Has $260,000 Position in Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) - Defense World
Where are the Opportunities in (DAWN) - news.stocktradersdaily.com
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Finanzdaten der Day One Biopharmaceuticals Inc-Aktie (DAWN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):